4160 Stock Overview
Provides genetic testing and informatics services in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Genetics Generation Advancement Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$72.20 |
| 52 Week High | NT$150.87 |
| 52 Week Low | NT$38.26 |
| Beta | 0.54 |
| 1 Month Change | 7.28% |
| 3 Month Change | -14.86% |
| 1 Year Change | 77.23% |
| 3 Year Change | 225.72% |
| 5 Year Change | 188.48% |
| Change since IPO | 71.76% |
Recent News & Updates
Shareholder Returns
| 4160 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 5.7% | -6.9% | 2.6% |
| 1Y | 77.2% | 12.1% | 23.3% |
Return vs Industry: 4160 exceeded the TW Biotechs industry which returned 11.4% over the past year.
Return vs Market: 4160 exceeded the TW Market which returned 22.3% over the past year.
Price Volatility
| 4160 volatility | |
|---|---|
| 4160 Average Weekly Movement | 5.2% |
| Biotechs Industry Average Movement | 5.3% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.9% |
| 10% least volatile stocks in TW Market | 2.0% |
Stable Share Price: 4160 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4160's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | n/a | www.gga.asia |
Genetics Generation Advancement Corp. provides genetic testing and informatics services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, neonatology and pediatrics testing, gastroenterology and hepatology, oncology, and medical research services. It also provides life sciences, materials sciences, research and development management, enterprise quality management, process production operation, and e-submission products.
Genetics Generation Advancement Corp. Fundamentals Summary
| 4160 fundamental statistics | |
|---|---|
| Market cap | NT$1.93b |
| Earnings (TTM) | NT$58.49m |
| Revenue (TTM) | NT$664.37m |
32.9x
P/E Ratio2.9x
P/S RatioIs 4160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4160 income statement (TTM) | |
|---|---|
| Revenue | NT$664.37m |
| Cost of Revenue | NT$381.42m |
| Gross Profit | NT$282.95m |
| Other Expenses | NT$224.46m |
| Earnings | NT$58.49m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.19 |
| Gross Margin | 42.59% |
| Net Profit Margin | 8.80% |
| Debt/Equity Ratio | 5.2% |
How did 4160 perform over the long term?
See historical performance and comparisonDividends
0.7%
Current Dividend Yield22%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 08:33 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Genetics Generation Advancement Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |